Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
Sales | 824 | 899 | 963 | 1,175 | 1,239 |
Gross Profit | 824 | 899 | 963 | 1,175 | 1,239 |
Operating Expenses | 1,133 | 1,175 | 1,093 | 1,299 | 1,290 |
Operating Income | -309 | -276 | -130 | -124 | -51 |
Pre-tax Income | -309 | -276 | -130 | -124 | -51 |
Net Income Continuous | -309 | -276 | -130 | -124 | -51 |
Net Income | $-309 | $-276 | $-130 | $-124 | $-51 |
EPS Basic Total Ops | -0.12 | -0.08 | -0.04 | -0.04 | N/A |
EPS Basic Continuous Ops | -0.14 | -0.08 | -0.04 | -0.04 | 0.00 |
EPS Diluted Total Ops | -0.10 | -0.10 | -0.04 | -0.04 | N/A |
EPS Diluted Continuous Ops | -0.14 | -0.08 | -0.04 | -0.04 | 0.00 |
EBITDA(a) | $129 | $-202 | $-54 | $-46 | $28 |